Literature DB >> 2014237

Characterization of a dopamine receptor (DA2K) in the kidney inner medulla.

T Huo1, M Q Ye, D P Healy.   

Abstract

Dopamine (DA) produces a natriuretic/diuretic response in the kidney by mechanisms that are still not well understood. There is some indication that DA2 receptors may be involved in mediating the effects of DA, but little is known regarding the nature of this receptor in the kidney. Autoradiographic localization of [3H]spiperone, a DA2 antagonist, indicated that high-density binding was restricted to inner medullary collecting ducts (IMCDs). [3H]Spiperone binding was saturable, high affinity (Kd, 17.2 +/- 1.65 nM), and high density (Bmax, 935 +/- 83 fmol per mg of protein). The photosensitive spiperone analogue N-(p-azido-m-[125I]iodophenethyl)spiperone labeled similar sized proteins of Mr = 120,000 in membranes prepared from the kidney inner medulla, striatum, and pituitary. However, the rank-order competition profile for the [3H]spiperone binding in the kidney inner medulla differed from the DA2 receptor in striatum and pituitary and, furthermore, RNA (Northern) blot analyses of kidney inner medullary RNA with brain DA2 receptor oligonucleotide probes were negative. Functionally, DA stimulated prostaglandin E2 production by IMCD cells, an effect that could be blocked by the DA2 antagonist domperidone. These results indicate that the kidney inner medulla expresses a functional DA receptor that may represent a newly identified DA receptor subtype (here designated DA2K). Moreover, these results suggest that the kidney inner medulla may be a significant site at which DA, either directly or indirectly, influences water and electrolyte excretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014237      PMCID: PMC51407          DOI: 10.1073/pnas.88.8.3170

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

2.  Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system?

Authors:  L I Goldberg; J D Kohli
Journal:  Commun Psychopharmacol       Date:  1979

Review 3.  Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.

Authors:  M F Lokhandwala; R J Barrett
Journal:  J Auton Pharmacol       Date:  1982-09

4.  Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule.

Authors:  S Muto; K Tabei; Y Asano; M Imai
Journal:  Eur J Pharmacol       Date:  1985-08-27       Impact factor: 4.432

5.  Production of urine free dopamine from DOPA; a micropuncture study.

Authors:  A D Baines; W Chan
Journal:  Life Sci       Date:  1980-01-28       Impact factor: 5.037

6.  Interactions of vasopressin, prostaglandins, and cAMP in rat renal papillary collecting tubule cells in culture.

Authors:  M Sato; M J Dunn
Journal:  Am J Physiol       Date:  1984-09

7.  Effects of bromocriptine on single nephron and whole-kidney function in rats.

Authors:  C T Stier; E A Cowden; M E Allison
Journal:  J Pharmacol Exp Ther       Date:  1982-02       Impact factor: 4.030

8.  Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390.

Authors:  E D Frederickson; T Bradley; L I Goldberg
Journal:  Am J Physiol       Date:  1985-08

Review 9.  Dopamine and the kidney.

Authors:  M R Lee
Journal:  Clin Sci (Lond)       Date:  1982-05       Impact factor: 6.124

10.  Effects of dopamine on renal function in the rat isolated perfused kidney.

Authors:  B McGrath; K Bode; A Luxford; B Howden; P Jablonski
Journal:  Clin Exp Pharmacol Physiol       Date:  1985 Jul-Aug       Impact factor: 2.557

View more
  1 in total

1.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.